These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16202380)

  • 21. Resistance to cabergoline as compared with bromocriptine in hyperprolactinemia: prevalence, clinical definition, and therapeutic strategy.
    Di Sarno A; Landi ML; Cappabianca P; Di Salle F; Rossi FW; Pivonello R; Di Somma C; Faggiano A; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2001 Nov; 86(11):5256-61. PubMed ID: 11701688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Masked hyperprolactinemia: tumor-derived factors inhibiting prolactin secretion caused by pituitary-stalk damage.
    Kinoshita Y; Hama S; Tominaga A; Arita K; Sugiyama K; Sakoguchi T; Usui S; Kurisu K
    J Clin Neurosci; 2011 Dec; 18(12):1651-5. PubMed ID: 22015098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Macroprolactinemia and Empty Sella Syndrome.
    Taieb A; Maha KN; El Abed YH; Beizig AM; Chadli MC; Ach K
    Pan Afr Med J; 2017; 27():278. PubMed ID: 29187947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current treatment issues in female hyperprolactinaemia.
    Crosignani PG
    Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):152-64. PubMed ID: 16288952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sella turcica abnormalities in an anovulatory population.
    Jones JR; Kemmann E
    Obstet Gynecol; 1976 Jul; 48(1):76-8. PubMed ID: 934579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acromegaly with moderate hyperprolactinemia caused by an intrasellar macroadenoma.
    Bonert VS; Melmed S
    Nat Clin Pract Endocrinol Metab; 2006 Jul; 2(7):408-12; quiz following 412. PubMed ID: 16932323
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hyperprolactinemia presenting with encephalomalacia-associated seizure disorder and infertility: a novel application for bromocriptine therapy in reproductive endocrinology.
    Saie DJ; Sills ES
    Neuro Endocrinol Lett; 2005 Oct; 26(5):533-5. PubMed ID: 16264405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug treatment of hyperprolactinemia.
    Chanson P; Borson-Chazot F; Chabre O; Estour B
    Ann Endocrinol (Paris); 2007 Jun; 68(2-3):113-7. PubMed ID: 17532288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidelines for the diagnosis and treatment of hyperprolactinemia.
    Biller BM; Luciano A; Crosignani PG; Molitch M; Olive D; Rebar R; Sanfilippo J; Webster J; Zacur H
    J Reprod Med; 1999 Dec; 44(12 Suppl):1075-84. PubMed ID: 10649814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current treatment options for hyperprolactinemia.
    Faje A; Nachtigall L
    Expert Opin Pharmacother; 2013 Aug; 14(12):1611-25. PubMed ID: 23738973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disconnection hyperprolactinaemia in nonadenomatous sellar/parasellar lesions practically never exceeds 2000 mU/l.
    Korevaar T; Wass JA; Grossman AB; Karavitaki N
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):602-3. PubMed ID: 21942983
    [No Abstract]   [Full Text] [Related]  

  • 32. Studies on the regulatory effect of Peony-Glycyrrhiza Decoction on prolactin hyperactivity and underlying mechanism in hyperprolactinemia rat model.
    Wang D; Wang W; Zhou Y; Wang J; Jia D; Wong HK; Zhang ZJ
    Neurosci Lett; 2015 Oct; 606():60-5. PubMed ID: 26297122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Female hyperprolactinaemia. 19 cases (author's transl)].
    Bercovici JP; Darragon T; Khoury S; Caroff J
    Nouv Presse Med; 1979 Nov; 8(46):3807-11. PubMed ID: 574954
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pituitary imaging is indicated for the evaluation of hyperprolactinemia.
    Bayrak A; Saadat P; Mor E; Chong L; Paulson RJ; Sokol RZ
    Fertil Steril; 2005 Jul; 84(1):181-5. PubMed ID: 16009175
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperprolactinemic ovarian insufficiency].
    Rjosk HK; Berg D; von Werder K
    Wien Med Wochenschr; 1984 Sep; 134(17):388-92. PubMed ID: 6437085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intrasellar germinoma treated with low-dose radiation.
    Li CS
    Acta Neurochir (Wien); 2006 Jul; 148(7):795-9; discussion 799. PubMed ID: 16670838
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of measuring macroprolactin in the differential diagnosis of hyperprolactinemic patients.
    Lu CC; Hsieh CJ
    Kaohsiung J Med Sci; 2012 Feb; 28(2):94-9. PubMed ID: 22313536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Misleading diagnosis of hyperprolactinemia in women].
    Paepegaey AC; Veron L; Wimmer MC; Christin-Maitre S
    Gynecol Obstet Fertil; 2016 Mar; 44(3):181-6. PubMed ID: 26966035
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Time Course of Resolution of Hyperprolactinemia After Transsphenoidal Surgery Among Patients Presenting with Pituitary Stalk Compression.
    Zaidi HA; Cote DJ; Castlen JP; Burke WT; Liu YH; Smith TR; Laws ER
    World Neurosurg; 2017 Jan; 97():2-7. PubMed ID: 27671881
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug insight: Cabergoline and bromocriptine in the treatment of hyperprolactinemia in men and women.
    Colao A; Di Sarno A; Guerra E; De Leo M; Mentone A; Lombardi G
    Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):200-10. PubMed ID: 16932285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.